Regeneron Pharmaceuticals

We track 4 ClinicalTrials.gov studies led by Regeneron Pharmaceuticals. The portfolio skews toward Phase 2 (3 trials).

4 clinical trials sponsored by Regeneron Pharmaceuticals.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 3
75%
Phase 3 1
25%

Trial Status Breakdown

Trials by Regeneron Pharmaceuticals

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of REGN7508, a Monoclonal Antibody Against FXI, for Primary Prophylaxis of Cancer-Associated Thrombosis for Participants With Solid Tumors Undergoing Cancer Treatment (ROXI-CAT-I)

NCT07410117 · RECRUITING · Phase 3

A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B

NCT06379789 · RECRUITING · Phase 2

A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT04626635 · RECRUITING · Phase 2

A Multi-Cohort Exploratory Study of Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC

NCT03916627 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Regeneron Pharmaceuticals sponsor?

Regeneron Pharmaceuticals currently sponsors 4 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 3.

What conditions does Regeneron Pharmaceuticals research?

Regeneron Pharmaceuticals conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Regeneron Pharmaceuticals recruiting for clinical trials?

Yes, Regeneron Pharmaceuticals currently has 3 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More